Join our keynote expert, Keith Elliston, Co-Founder of Ingentium, as he explores the significant role that technology plays in advancing scientific research by promoting collaboration, privacy, security, and governance to advance a healthier future. Discover how innovative biotech solutions enable transformative improvements across the drug discovery & development process for better patient outcomes.
Find out how Cat Hall, VP of Data & Quality at Endpoint Clinical, has innovated with its vendors, to develop software that preserves compliance, manages audit trails, and ensures data integrity during clinical trials.
Join Nate McBride, Senior VP of IT at Xilio Therapeutics, as he sheds light on the fundamental elements biotech IT leaders must consider as they evolve. Nate will provide a comprehensive overview of the dos and don'ts, offer launchpad guidance tailored for emerging biotechs, and provide tips on fostering secure collaboration within their organization.
Join Mike Stackhouse, the CIO of Atorus, for a discussion on the Pharmaverse and how organizations in the pharmaceutical industry are creating open-source R packages for clinical reporting usage in pharma and the search for the next generation of regulatory reporting.
Find out from Luke Bogus, Group Product Manager of Vial, how a modern CRO can reduce costs and accelerate their workflows during clinical trials by integrating an easy-to-deploy eTMF into their tech stack.
Scientists can now generate more data in a single day than they could in the preceding decade. Today, translating this deluge of data into actionable insights has become the rate-limiting step to scientific discovery. Researchers struggle to access the computational infrastructure, niche informatics tooling, and data science expertise required to realize the full potential of their experiments. Dr. Mark Kalinich discusses these challenges, reviews the available solutions, and shares how Watershed's Omics Bench brings together these disparate resources into one unified ecosystem on the cloud, empowering scientists to transform today’s fragmented data into tomorrow’s precision medicines.
Ford Winslow, CEO of ICE Cybersecurity and Neil Jones, Egnyte’s Cybersecurity Evangelist, discuss practical approaches that you can take to protect your company’s sensitive biotech data from potential cyberattacks. Approaches will include: Designing your data footprint with the right balance of access, collaboration and security, detecting and quantifying risk to your organization’s data and implementing an incident response plan, so you can recover quickly from potential attacks.
Hear from the experts on the best practices to streamline clinical data management, optimize clinical research productivity, and innovative methods to modernize your clinical trial approaches.